ZYBT

Zhengye Biotechnology Holding Ltd

1.40

Oct 16 • 3:59 PM ET -0.10 (-6.67%)

1.40

Aftermarket • 7:42 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - Specialty & Generic China Nano NASD

Peers: INCR OPTH ANIK LFCR TKNO OGI ADCT DERM ACB CRDL

Scroll to Statements

Index	-
Market Cap	41.62M
Enterprise Value	53.07M
Income	-9.74M
Sales	16.18M
Book/sh	0.75
Cash/sh	0.25
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	269
IPO	Jan 07, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	2.57
P/B	1.86
P/C	5.60
P/FCF	24.06
EV/EBITDA	-
EV/Sales	3.28
Quick Ratio	0.80
Current Ratio	1.14
Debt/Eq	0.30
LT Debt/Eq	0.04
Option/Short	No / Yes

EPS (ttm)	-0.21
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	-25.18% -16.43%
EPS Y/Y TTM	-717.42%
Sales Y/Y TTM	-37.53%
EPS Q/Q	-2195.59%
Sales Q/Q	-40.44%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	74.09%
Insider Trans	0.00%
Inst Own	0.34%
Inst Trans	-7.08%
ROA	-14.98%
ROE	-26.09%
ROIC	-26.28%
Gross Margin	20.41%
Oper. Margin	-60.73%
Profit Margin	-60.22%
SMA20	4.50%
SMA50	-8.11%
SMA200	22.70%
Trades

Shs Outstand	29.73M
Shs Float	7.70M
Short Float	1.49%
Short Ratio	0.02
Short Interest	0.12M
52W High	8.01 -82.52%
52W Low	0.62 127.46%
Volatility	20.28% 17.02%
ATR (14)	0.25
RSI (14)	49.31
Beta	-2.29
Rel Volume	0.01
Avg Volume	5.55M
Volume	81,605

Perf Week	-19.08%
Perf Month	2.19%
Perf Quarter	-82.52%
Perf Half Y	41.34%
Perf YTD	21.74%
Perf Year	-45.31%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	1.50
Price	1.40
Change %	-6.67%

Aug-06-26 08:00AM	Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement (GlobeNewswire) -11.44%
Jul-21-26 10:34AM	Zhengye Biotechnology Says No Material Events Behind Unusual Trading Activity (NASDAQ:ZYBT) (InvestorsHub) -64.42%
08:30AM	Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity (GlobeNewswire)
Jun-04-26 04:05PM	Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Apr-28-26 04:30PM	Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results (PR Newswire) -5.69%
09:25AM	Loading…
Apr-06-26 09:25AM	Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure (GlobeNewswire)
Feb-10-26 08:30AM	Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders (GlobeNewswire)
Jul-03-25 08:30AM	Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results (PR Newswire)
May-23-25 04:05PM	Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F (GlobeNewswire) -12.33%
Jan-14-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option (GlobeNewswire)
Jan-08-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering (GlobeNewswire) -7.41%
Jan-06-25 05:50PM	Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

Co-Chief Executive OfficerMr. Songlin Song

Chief Financial OfficerMr. Ping Wang

Chief Operating OfficerMr. Zhongyao Liu

Vice General ManagerMs. Yuhong Cheng

Co-Chief Executive OfficerMr. Aiden Han

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vanguards Skyline Holdings Lim	Shareholder	Nov 01 '25	Proposed Sale	12.91	2,278,752	29,419,666		Oct 22 04:10 PM
VVAX Holdings Limited	Shareholder	Nov 01 '25	Proposed Sale	2.62	684,996	1,794,690		Oct 22 04:10 PM

ZYBT

Zhengye Biotechnology Holding Ltd

Upgrade your Finviz experience